Literature DB >> 12643141

Prediabetes mellitus and its links to atherosclerosis.

Daniel Kramer1, Annaswamy Raji, Jorge Plutzky.   

Abstract

Type 2 diabetes mellitus is a chronic insidious process contributing to an overwhelming amount of morbidity and mortality, much of which is related to atherosclerosis, which often accompanies and complicates the natural history of diabetes. Although considerable attention has focused on new insights into diabetic mechanisms and emerging treatments, perhaps one of the greatest opportunities for decreasing the toll of diabetes and its late-stage complications may be intervening earlier in the disease process. Such notions redirect attention toward the concept of prediabetes mellitus as a potentially discrete syndrome, which may be identifiable in clinical practice. This article seeks to offer support for this hypothesis by considering the data surrounding prediabetes mellitus, with particular attention on the mechanistic and clinical links to atherosclerosis.

Entities:  

Mesh:

Year:  2003        PMID: 12643141     DOI: 10.1007/s11892-003-0047-4

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  61 in total

Review 1.  Primary prevention of type 2 diabetes in high-risk populations.

Authors:  S B Harris; B Zinman
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

Review 2.  Insulin resistance and cardiovascular disease.

Authors:  H N Ginsberg
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 3.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 4.  Impaired glucose tolerance, insulin resistance and cardiovascular disease.

Authors:  S M Haffner
Journal:  Diabet Med       Date:  1997-08       Impact factor: 4.359

5.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

6.  Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state.

Authors:  S M Haffner; L Mykkänen; A Festa; J P Burke; M P Stern
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

7.  TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus.

Authors:  S P Azen; R K Peters; K Berkowitz; S Kjos; A Xiang; T A Buchanan
Journal:  Control Clin Trials       Date:  1998-04

8.  Lifestyle intervention in overweight individuals with a family history of diabetes.

Authors:  R R Wing; E Venditti; J M Jakicic; B A Polley; W Lang
Journal:  Diabetes Care       Date:  1998-03       Impact factor: 19.112

9.  Do different dimensions of the metabolic syndrome change together over time? Evidence supporting obesity as the central feature.

Authors:  P Maison; C D Byrne; C N Hales; N E Day; N J Wareham
Journal:  Diabetes Care       Date:  2001-10       Impact factor: 19.112

10.  U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.

Authors: 
Journal:  Diabetes       Date:  1995-11       Impact factor: 9.461

View more
  3 in total

Review 1.  Are thiazolidinediones good or bad for the heart?

Authors:  Angela M Taylor; Coleen A McNamara
Journal:  Curr Diab Rep       Date:  2006-11       Impact factor: 4.810

2.  Cardiometabolic risk management in type 2 diabetes and obesity.

Authors:  Angela M Taylor
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

3.  Correlation between prediabetes and coronary artery disease severity in patients undergoing elective coronary angiography.

Authors:  Ahmed Muhammed; Mohamed Tarek Zaki; Ahmed Shawky Elserafy; Sameh Attia Amin
Journal:  Egypt Heart J       Date:  2019-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.